These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 2465078

  • 1. In vivo 31P MRS in new antineoplastic agents evaluation on experimental tumor models.
    Le Moyec L, Naruse S, Higuchi T, Hirakawa K, Watari H, de Certaines JD, Roques BP.
    Cancer Biochem Biophys; 1988 Jul; 10(1):31-45. PubMed ID: 2465078
    [Abstract] [Full Text] [Related]

  • 2. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.
    Naruse S, Hirakawa K, Horikawa Y, Tanaka C, Higuchi T, Ueda S, Nishikawa H, Watari H.
    Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784
    [Abstract] [Full Text] [Related]

  • 3. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
    Winter PM, Poptani H, Bansal N.
    Cancer Res; 2001 Mar 01; 61(5):2002-7. PubMed ID: 11280759
    [Abstract] [Full Text] [Related]

  • 4. In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology.
    Steen RG, Tamargo RJ, McGovern KA, Rajan SS, Brem H, Wehrle JP, Glickson JD.
    Cancer Res; 1988 Feb 01; 48(3):676-81. PubMed ID: 3335030
    [Abstract] [Full Text] [Related]

  • 5. [A high-resolution 31P-NMR study of the disorders in the energy metabolic system of Ehrlich ascites cancer cells exposed to antitumor preparations].
    Semenova NA, Shchelok EP, Ostrovskaia LA, Sibel'dina LA.
    Izv Akad Nauk SSSR Biol; 1991 Feb 01; (5):794-8. PubMed ID: 1795075
    [Abstract] [Full Text] [Related]

  • 6. [The effect of antitumor preparations on the energy metabolism of melanoma B16 in mice. A 31P-NMR method in vivo].
    Shkarin PIu, Sokolova IS, Gorbacheva LB, Sibel'dina LA.
    Dokl Akad Nauk SSSR; 1989 Feb 01; 309(4):996-9. PubMed ID: 2635671
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I, Hasmann M, Saltz LB, Koutcher JA.
    Clin Cancer Res; 2005 May 01; 11(9):3503-13. PubMed ID: 15867253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
    Aboagye EO, Dillehay LE, Bhujwalla ZM, Lee DJ.
    Radiat Oncol Investig; 1998 May 01; 6(6):249-54. PubMed ID: 9885940
    [Abstract] [Full Text] [Related]

  • 12. Effect of pentoxifylline on the ischemic rat kidney monitored by 31P NMR spectroscopy in vivo.
    Ellermann J, Gründer W, Keller T.
    Biomed Biochim Acta; 1988 May 01; 47(6):515-21. PubMed ID: 3240301
    [Abstract] [Full Text] [Related]

  • 13. [In vivo 31P NMR studies on cerebral infarction using topical magnetic resonance (TMR)--time course of high energy phosphorus compounds content in ischemic and recirculated brain].
    Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Koizuka I, Takada S, Watari H.
    No To Shinkei; 1983 Jun 01; 35(6):603-9. PubMed ID: 6626382
    [No Abstract] [Full Text] [Related]

  • 14. [Application of multinuclear in vivo magnetic resonance spectroscopy in oncology].
    Semmler W, Gückel F, Bachert-Baumann P, Lorenz WJ, van Kaick G.
    Radiologe; 1989 Jul 01; 29(7):330-5. PubMed ID: 2667032
    [Abstract] [Full Text] [Related]

  • 15. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL, Rodriguez M, Powis G.
    Cancer Res; 1989 Feb 15; 49(4):977-82. PubMed ID: 2912564
    [Abstract] [Full Text] [Related]

  • 16. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.
    Evelhoch JL, Bissery MC, Chabot GG, Simpson NE, McCoy CL, Heilbrun LK, Corbett TH.
    Cancer Res; 1988 Sep 01; 48(17):4749-55. PubMed ID: 3409216
    [Abstract] [Full Text] [Related]

  • 17. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
    Kaplan O, Kushnir T, Askenazy N, Knubovets T, Navon G.
    Cancer Res; 1997 Apr 15; 57(8):1452-9. PubMed ID: 9108445
    [Abstract] [Full Text] [Related]

  • 18. Insulin protects against hepatic bioenergetic deterioration induced by cancer cachexia: an in vivo 31P magnetic resonance spectroscopy study.
    Brauer M, Inculet RI, Bhatnagar G, Marsh GD, Driedger AA, Thompson RT.
    Cancer Res; 1994 Dec 15; 54(24):6383-6. PubMed ID: 7987832
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 15; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 20. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK.
    Clin Cancer Res; 2000 Apr 15; 6(4):1498-507. PubMed ID: 10778982
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.